Consensus opinion on immune-mediated cytopenias after hematopoietic cell transplant for inherited metabolic disorders-Reference-Cited by-同舟云学术

Consensus opinion on immune-mediated cytopenias after hematopoietic cell transplant for inherited metabolic disorders

Published:2021-01-13 Issue:6 Volume:56 Page:1238-1247
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Gupta Ashish O.^ORCID,Jan Boelens Jaap^ORCID,Ebens Christen L.,Kurtzberg Joanne,Lund Troy C.,Smith Angela R.,Wagner John E.,Wynn Robert,Blazar Bruce R.,Orchard Paul J.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-020-01179-5.pdf

Reference48 articles.

1. Chen FE, Owen I, Savage D, Roberts I, Apperley J, Goldman JM, et al. Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant. Bone Marrow Transplant. 1997;19:491–5.

2. Dovat S, Roberts RL, Wakim M, Stiehm ER, Feig SA. Immune thrombocytopenia after umbilical cord progenitor cell transplant: response to vincristine. Bone Marrow Transplant. 1999;24:321–3.

3. Horn B, Viele M, Mentzer W, Mogck N, DeSantes K, Cowan M. Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantation. Bone Marrow Transplant. 1999;24:1009–13.

4. Bhatt V, Shune L, Lauer E, Lubin M, Devlin SM, Scaradavou A, et al. Autoimmune hemolysis and immune thrombocytopenic purpura after cord blood transplantation may be life-threatening and warrants early therapy with rituximab. Bone Marrow Transplant. 2016;51:1579–83.

5. Chang TY, Jaing TH, Wen YC, Huang IA, Chen SH, Tsay PK. Risk factor analysis of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation in children. Medicine. 2016;95:e5396.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutrophil antigen antibodies affect engraftment and secondary graft failure in hematopoietic progenitor cell transplantation;Transfusion;2024-04-18

2. Successful sequential therapy with rituximab and daratumumab for refractory posttransplant immune thrombocytopenic purpura;Pediatric Blood & Cancer;2023-05-29

3. Immune-mediated cytopenias (IMCs) after HSCT for pediatric non-malignant disorders: epidemiology, risk factors, pathogenesis, and treatment;European Journal of Pediatrics;2023-03-27

4. Current Situation and Prospect of Adoptive Cellular Immunotherapy for Malignancies;Technology in Cancer Research & Treatment;2023-01

5. A Clinical Tool to Predict the Microvascular Invasion Risk in Patients with Hepatocellular Carcinoma;Technology in Cancer Research & Treatment;2023-01